prurigo
prurigo
Explore linked clinical trials. Standard reference: MONDO:00217391 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients | Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, dermatitis, prurigo, skin disorder | Not yet recruiting | Phase 2 | 2026-09-03 | NCT07620561 |